Back to Newsroom

Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27

ZUG, Switzerland, Sept. 20, 2017 — Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that Thomas Meyer, Ph.D., Chairman and Chief Executive Officer, will present at the LEERINK Partners Rare Disease Roundtable Series in New York City on Wednesday, September 27, 2017, at 9:30 a.m. Eastern Time.
READ MORE…